======= FUT7 =======
== Gene Information ==
* **Official Symbol**: FUT7
* **Official Name**: fucosyltransferase 7
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2529|2529]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q11130|Q11130]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=FUT7&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FUT7|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/602030|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene is a Golgi stack membrane protein that is involved in the creation of sialyl-Lewis X antigens. The encoded protein can direct the synthesis of the E-selectin-binding sialyl-Lewis X moiety. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Catalyzes alpha-1,3 glycosidic linkages involved in the expression of sialyl Lewis X antigens. {ECO:0000269|PubMed:11404359, ECO:0000269|PubMed:8207002, ECO:0000269|PubMed:9299472}.
|Glyco transf 10|
|leukocyte migration involved in immune response|
|CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation|
|regulatory T cell differentiation|
|alpha-(1->3)-fucosyltransferase activity|
|fucosyltransferase activity|
|L-fucose catabolic process|
|fucose catabolic process|
|L-fucose metabolic process|
|fucose metabolic process|
|fucosylation|
|CD4-positive, alpha-beta T cell differentiation|
|CD4-positive, alpha-beta T cell activation|
|alpha-beta T cell differentiation|
|hexose catabolic process|
|alpha-beta T cell activation|
|monosaccharide catabolic process|
|ceramide metabolic process|
|Golgi cisterna membrane|
|carbohydrate catabolic process|
|T cell differentiation|
|sphingolipid metabolic process|
|hexose metabolic process|
|monosaccharide metabolic process|
|membrane lipid metabolic process|
|T cell activation|
|lymphocyte differentiation|
|macromolecule glycosylation|
|protein glycosylation|
|glycosylation|
|glycoprotein biosynthetic process|
|leukocyte differentiation|
|leukocyte migration|
|lymphocyte activation|
|glycoprotein metabolic process|
|small molecule catabolic process|
|carbohydrate metabolic process|
|hemopoiesis|
|hematopoietic or lymphoid organ development|
|carbohydrate derivative biosynthetic process|
|immune system development|
|cellular amide metabolic process|
|leukocyte activation|
|cellular lipid metabolic process|
|cell migration|
|Golgi apparatus|
|carbohydrate derivative metabolic process|
|cell activation|
|cell motility|
|localization of cell|
|immune effector process|
|lipid metabolic process|
|locomotion|
|organonitrogen compound biosynthetic process|
|movement of cell or subcellular component|
|cellular macromolecule biosynthetic process|
|small molecule metabolic process|
|macromolecule biosynthetic process|
|organic substance catabolic process|
|immune response|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|1.72|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 5570
* **Expression level (log2 read counts)**: -1.56
{{:chemogenomics:nalm6 dist.png?nolink |}}